Stocks
Repligen CorporationRGEN
NASDAQHealthcareLife Sciences Tools & Services$114.20+0.39%
Supplies bioprocessing technologies used by pharmaceutical and biotechnology companies to manufacture biologic drugs. Its products include filtration systems, chromatography components, and process analytics used in the production of monoclonal antibodies, vaccines, and gene therapies. Investors tra...
Market Cap: $6.4B52W Range: $102.97 – $175.77
Congressional Interest in Repligen Corporation (RGEN)
4 members of Congress have disclosed 9 trades in Repligen Corporation (RGEN), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
4
Buys
4
Sells
5
Who in Congress Is Trading RGEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |
| 2025-10-30 | Lisa McClain | sell | $1K – $15K |